1. Summary Information
|
|
|
Country |
|
|
Company Name |
UNITED BIOTECH PRIVATE LIMITED |
Principal Name 1 |
Mr. Rajiv Kumar |
|
Status |
Satisfactory |
Principal Name 2 |
Mrs. Kavita Gakhar |
|
|
|
Registration # |
55-84814 |
|
Street Address |
United House, E-142, Saket, |
||
|
Established Date |
31.01.1997 |
SIC Code |
-- |
|
Telephone# |
91-11-26855082/
40651100 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-11-26855082/
66607096 |
Business Style 2 |
-- |
|
Homepage |
Product Name 1 |
Formulations, |
|
|
# of employees |
-- |
Product Name 2 |
Injections |
|
Paid up capital |
Rs.
45,363,300/- |
Product Name 3 |
-- |
|
Shareholders |
Directors or relatives of directors 100.00% |
Banking |
Oriental Bank of Commerce |
|
Public Limited Corp. |
NO |
Business Period |
13 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
Ba (45) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2009 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
371,338,000 |
Current Liabilities |
107,967,000 |
|
Inventories |
174,717,000 |
Long-term Liabilities |
[932,000] |
|
Fixed Assets |
459,201,000 |
Other Liabilities |
43,535,000 |
|
Deferred Assets |
442,000 |
Total Liabilities |
150,570,000 |
|
Invest& other Assets |
000 |
Retained Earnings |
809,765,000 |
|
|
|
Net Worth |
855,128,000 |
|
Total Assets |
1,005,698,000 |
Total Liab. & Equity |
1,005,698,000 |
|
Total Assets (Previous Year) |
633,599,000 |
|
|
|
P/L Statement as of |
31.03.2009 |
(Unit: Indian Rs.) |
|
|
Sales |
803,512,000 |
Net Profit |
291,277,000 |
|
Sales(Previous yr) |
590,114,000 |
Net Profit(Prev.yr) |
224,789,000 |
MIRA
INFORM REPORT
|
Report Date : |
05.05.2011 |
IDENTIFICATION DETAILS
|
Name : |
UNITED BIOTECH PRIVATE LIMITED |
|
|
|
|
Registered Office : |
United House, E-142, Saket, New Delhi – 110 017 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2009 |
|
|
|
|
Date of Incorporation : |
31.01.1997 |
|
|
|
|
Com. Reg. No.: |
55-84814 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24239DL1997PTC084814 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
DELU02630F |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACU1839L |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of
Pharmaceutical Products such as formulations, injections etc. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 3400000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well
established company having satisfactory track. Directors are reported as
experienced, respectable and resourceful businessmen. Their trade relations
are fair. Payments are usually correct and as per commitments. The company can
be considered normal for business dealings at usual trade terms and
conditions. Slight caution
needs to be exercised in view of non-availability of latest financials. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
United House, E-142, Saket, |
|
Tel. No.: |
91-11-26855082/
40651100 |
|
Mobile No.: |
91-9810906070
(Mr. Sanjeev Kumar) |
|
Fax No.: |
91-11-26855082/
66607096 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
50000 sq ft |
|
Location : |
Owned (by
company) |
|
|
|
|
Head Office : |
3208, IInd Floor, |
|
Tel. No.: |
91-11-27033003/ 47024666 |
|
Fax No.: |
91-11-47565866 |
|
E-Mail : |
|
|
|
|
|
Corporate Office : |
Plot – F,
C-Block, B-1 Mohan Co-operative Industrial Estate, |
|
Tel. No.: |
91-11-40651100/
66607095/ 66403098/ 99/ 26940762 |
|
Fax No.: |
91-11-66607096/
66607091 |
|
E mial: |
|
|
Location : |
Industrial |
|
|
|
|
Factory : |
Bagbania, Baddi, |
|
Te. No.: |
91-1795-236904/5/6 |
|
Fax No.: |
91-1795-236604 |
|
E-Mail : |
|
|
|
|
|
Branch Office : |
‘Nithya Sadan’ # 49, G-001, Krishnappa Layout, Sanjay Nagar,
Bangalore-560094, |
|
Tel. No.: |
91-80-65906402/ 42061042 |
|
E-Mail : |
DIRECTORS
As on 30.09.2010
|
Name : |
Mr. Rajiv Kumar |
|
Designation : |
Whole Time Director |
|
Address : |
E-142, Saket, |
|
Date of Birth/Age : |
09.04.1963 |
|
Qualification : |
Bachelor in Pharma |
|
Date of Appointment : |
31.01.1997 |
|
|
|
|
Name : |
Mrs. Kavita Gakhar |
|
Designation : |
Whole Time Director |
|
Address : |
E-142, Saket, |
|
Date of Birth/Age : |
11.10.1970 |
|
Qualification : |
MA |
|
Date of Appointment : |
01.08.2002 |
|
|
|
|
Name : |
Mrs. Kailash Devi Dhalu Ram Girdhar |
|
Designation : |
Whole Time Director |
|
Address : |
E-142, Saket, |
|
Date of Birth/Age : |
05.01.1937 |
|
Qualification : |
MA |
|
Date of Appointment : |
01.05.2002 |
|
|
|
|
Name : |
Mr. Sanjeev Kumar |
|
Designation : |
Whole-time Director |
|
Address : |
E-142, Saket Malviya Nagar, |
|
Date of Birth/Age : |
26.09.1966 |
|
Qualification : |
B. Pharma |
|
Date of Appointment : |
02.04.2007 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Rajiv Kumar |
|
59233 |
|
Kailash Devi |
|
59233 |
|
Kavita |
|
59234 |
|
Ashwani Kumar |
|
59233 |
|
Monika |
|
59233 |
|
Sanjeev Kumar |
|
98233 |
|
Preeti Gakhar |
|
59234 |
|
|
|
|
|
Total |
|
453633 |
As on 30.09.2010
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Directors
or relatives of directors |
|
100.00 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of
Pharmaceutical Products such as formulations, injections etc. |
|
|
|
|
Products : |
SOL-U-PRED
NEW RANGE
|
GENERAL INFORMATION
|
Bankers : |
|
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Financial Institution: |
Director of Industries, Through Deputy Director of Industries, Single
Window Clearance Agency, Nalagarh-173211, |
|
|
|
|
Auditors : |
|
|
Name : |
AVN and Associates Chartered Accountant |
|
Address : |
3208, II Floor, |
|
Tel. No.: |
91-11-27033003/47024666 |
|
Fax No.: |
91-11-47565866 |
|
E-Mail : |
CAPITAL STRUCTURE
As on 30.09.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs.100/- each |
Rs.50.000 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
453633 |
Equity Shares |
Rs.100/- each |
Rs.45.363
Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2009 |
31.03.2008 |
31.03.2007 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
45.363 |
45.363 |
45.363 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
809.765 |
484.360 |
232.702 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
855.128 |
529.723 |
278.065 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
(5.133) |
(8.964) |
20.980 |
|
|
2] Unsecured Loans |
4.200 |
4.300 |
4.300 |
|
|
TOTAL BORROWING |
(0.932) |
(4.664) |
25.280 |
|
|
DEFERRED TAX LIABILITIES |
1.837 |
1.486 |
1.379 |
|
|
|
|
|
|
|
|
TOTAL |
856.033 |
526.545 |
304.724 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
459.201 |
137.353 |
125.180 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.442 |
0.663 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
174.717
|
144.725
|
101.251
|
|
|
Sundry Debtors |
163.893
|
111.348
|
88.519
|
|
|
Cash & Bank Balances |
90.476
|
171.851
|
39.447
|
|
|
Other Current Assets |
81.368
|
40.043
|
29.072
|
|
|
Loans & Advances |
35.601
|
27.616
|
0.957
|
|
Total
Current Assets |
546.055
|
495.583 |
259.246 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
107.967
|
75.788
|
58.391
|
|
|
Provisions |
41.698
|
31.266
|
22.194
|
|
Total
Current Liabilities |
149.665
|
107.054
|
80.585
|
|
|
Net Current Assets |
396.390
|
388.529
|
178.661
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.883 |
|
|
|
|
|
|
|
|
TOTAL |
856.033 |
526.545 |
304.724 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2009 |
31.03.2008 |
31.03.2007 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
803.512 |
590.114 |
463.870 |
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
333.327 |
256.163 |
179.572 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
42.050 |
31.374 |
22.229 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
291.277 |
224.789 |
157.343 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
642.10 |
495.53 |
346.85 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2009 |
31.03.2008 |
31.03.2007 |
|
Net Profit Margin (PBT/Sales) |
(%) |
41.48
|
43.41 |
38.71 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
33.16
|
40.47 |
46.71 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.39
|
0.48 |
0.65 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.17 |
0.19
|
0.38
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
3.65 |
4.63
|
3.22
|
LOCAL AGENCY FURTHER INFORMATION
Business
Operations:
This year marked the year of full fledged commercial operation and
productions of Baddil Unit of the company. The company has also entered in the
Export Market.
The products of the company which are mainly in demand are Tazin,
Iminem, Cafoprim, Kephazon-S, Paclitec, Epirubitec, etc.
The company is dealing in all kinds of pharmaceutical formulations like
injectable, Tablets/ Capsules, Syrpus and Suspension etc. in the current year
they plan to manufacture various new medicines like voriconzole, fluconazole,
Pemetrexed, Tirofiban Hel. Monohydrate etc.
The company has performed well during the current financial year with a
turnover of Rs. 803.512 Millions and profit before tax of Rs. 333.327 Millions.
Bankers Charges
Report as per Registry
|
Corporate
identity number of the company |
U24239DL1997PTC084814 |
|
Name of the
company |
UNITED BIOTECH PRIVATE LIMITED |
|
Address of the registered
office or of the principal place of
business in |
E-142, Saket, |
|
This form is for |
Creation of
Charge |
|
Type of charge |
Others |
|
Particular of
charge holder |
Director of Industries,
Through Deputy Director of Industries, Single Window, Clearance Agency,
Nalagarh-173211, |
|
Nature of
instrument creating charge |
|
|
Date of
instrument Creating the charge |
21.07.2009 |
|
Amount secured by
the charge |
Rs. 3.000
Millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Extent and Operation
of the charge: To the extent of charge created |
|
Short particulars
of the property charged |
All Machinery and
Equipments belonging to the industrial concern lying at the site at Village
Tehilwal Dhana, Baddi Nalagarh Road, P.O. Manpura, District Solan, Himachal
Pradesh, India |
FIXED ASSETS:
- Land (at Baddi)
- Plant and Machinery
- Electrical Installation
- Furniture and Fixture
- Vehicles
- Computers
- Office Equipment
- Capital Work in Progress
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.59 |
|
|
1 |
Rs.73.42 |
|
Euro |
1 |
Rs.66.04 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
49 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.